ACCESS TO MEDICINES /
OUR WORK IN europE
WE PRESENT AN OPPOSITION TO THE PATENT FOR THE DRUG FOR HEPATITIS C
Salud por Derecho presented a new opposition to the patent of sofosvubir, the innovative drug for Hepatitis C patented by Gilead, to eliminate the barriers that limit access of millions of people to a drug necessary for life.
The opposition, presented in conjunction with 30 non-governmental and civil society organizations from 17 European countries, is based on the fact that the compound is not an invention and that, therefore, it is not compliant with the requirements defined by the European Patent Convention.
The opposition, presented in conjunction with 30 non-governmental and civil society organizations from 17 European countries, is based on the fact that the compound is not an invention and that, therefore, it is not compliant with the requirements defined by the European Patent Convention.